These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 33299524)

  • 1. Plasma Protein Carbonyls as Biomarkers of Oxidative Stress in Chronic Kidney Disease, Dialysis, and Transplantation.
    Colombo G; Reggiani F; Angelini C; Finazzi S; Astori E; Garavaglia ML; Landoni L; Portinaro NM; Giustarini D; Rossi R; Santucci A; Milzani A; Badalamenti S; Dalle-Donne I
    Oxid Med Cell Longev; 2020; 2020():2975256. PubMed ID: 33299524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress and antioxidative enzyme activities in chronic kidney disease and different types of renal replacement therapy.
    Stępniewska J; Gołembiewska E; Dołęgowska B; Domański M; Ciechanowski K
    Curr Protein Pept Sci; 2015; 16(3):243-8. PubMed ID: 25707472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic damage in patients with chronic kidney disease, peritoneal dialysis and haemodialysis: a comparative study.
    Rangel-López A; Paniagua-Medina ME; Urbán-Reyes M; Cortes-Arredondo M; Alvarez-Aguilar C; López-Meza J; Ochoa-Zarzosa A; Lindholm B; García-López E; Paniagua JR
    Mutagenesis; 2013 Mar; 28(2):219-25. PubMed ID: 23408844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Glutaredoxin Activity as a Marker of Oxidative Stress in Chronic Kidney Disease: A Pilot Study.
    Levin A; Nair D; Qureshi AR; Bárány P; Heimburger O; Anderstam B; Stenvinkel P; Bruchfeld A; Ungerstedt JS
    Nephron; 2018; 140(4):249-256. PubMed ID: 30253414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between biomarkers of carbonyl stress with increased systemic inflammatory response in different stages of chronic kidney disease and after renal transplantation.
    Aveles PR; Criminácio CR; Gonçalves S; Bignelli AT; Claro LM; Siqueira SS; Nakao LS; Pecoits-Filho R
    Nephron Clin Pract; 2010; 116(4):c294-9. PubMed ID: 20639676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood Thiol Redox State in Chronic Kidney Disease.
    Garavaglia ML; Giustarini D; Colombo G; Reggiani F; Finazzi S; Calatroni M; Landoni L; Portinaro NM; Milzani A; Badalamenti S; Rossi R; Dalle-Donne I
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients.
    Isoyama N; Leurs P; Qureshi AR; Bruchfeld A; Anderstam B; Heimburger O; Bárány P; Stenvinkel P; Lindholm B
    Nephrol Dial Transplant; 2015 Jan; 30(1):84-91. PubMed ID: 25074436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uremic Toxins, Oxidative Stress, Atherosclerosis in Chronic Kidney Disease, and Kidney Transplantation.
    Wojtaszek E; Oldakowska-Jedynak U; Kwiatkowska M; Glogowski T; Malyszko J
    Oxid Med Cell Longev; 2021; 2021():6651367. PubMed ID: 33628373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xanthine oxidoreductase activity in platelet-poor and rich plasma as a oxidative stress indicator in patients required renal replacement therapy.
    Cecerska-Heryć E; Heryć R; Dutkiewicz G; Michalczyk A; Grygorcewicz B; Serwin N; Napiontek-Balińska S; Dołęgowska B
    BMC Nephrol; 2022 Jan; 23(1):35. PubMed ID: 35042470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological Characteristics of Periodontal Disease in Patients with Chronic Kidney Disease and Kidney Transplantation.
    Kitamura M; Mochizuki Y; Miyata Y; Obata Y; Mitsunari K; Matsuo T; Ohba K; Mukae H; Yoshimura A; Nishino T; Sakai H
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden.
    Eriksson JK; Neovius M; Jacobson SH; Elinder CG; Hylander B
    BMJ Open; 2016 Oct; 6(10):e012062. PubMed ID: 27855091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mode of renal replacement therapy determines endotoxemia and neutrophil dysfunction in chronic kidney disease.
    Lemesch S; Ribitsch W; Schilcher G; Spindelböck W; Hafner-Gießauf H; Marsche G; Pasterk L; Payerl D; Schmerböck B; Tawdrous M; Rosenkranz AR; Stiegler P; Kager G; Hallström S; Oettl K; Eberhard K; Horvath A; Leber B; Stadlbauer V
    Sci Rep; 2016 Oct; 6():34534. PubMed ID: 27698480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic inflammation and oxidative stress in hemodialysis patients are associated with down-regulation of Nrf2.
    Pedruzzi LM; Cardozo LF; Daleprane JB; Stockler-Pinto MB; Monteiro EB; Leite M; Vaziri ND; Mafra D
    J Nephrol; 2015 Aug; 28(4):495-501. PubMed ID: 25585822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Could resistant starch supplementation improve inflammatory and oxidative stress biomarkers and uremic toxins levels in hemodialysis patients? A pilot randomized controlled trial.
    Esgalhado M; Kemp JA; Azevedo R; Paiva BR; Stockler-Pinto MB; Dolenga CJ; Borges NA; Nakao LS; Mafra D
    Food Funct; 2018 Dec; 9(12):6508-6516. PubMed ID: 30468238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial dysfunction and low-grade inflammation in the transition to renal replacement therapy.
    Gennip ACEV; Broers NJH; Meulen KJT; Canaud B; Christiaans MHL; Cornelis T; Gelens MACJ; Hermans MMH; Konings CJAM; Net JBV; Sande FMV; Schalkwijk CG; Stifft F; Wirtz JJJM; Kooman JP; Martens RJH
    PLoS One; 2019; 14(9):e0222547. PubMed ID: 31518378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Illness perceptions and treatment perceptions of patients with chronic kidney disease: different phases, different perceptions?
    Jansen DL; Heijmans MJ; Rijken M; Spreeuwenberg P; Grootendorst DC; Dekker FW; Boeschoten EW; Kaptein AA; Groenewegen PP
    Br J Health Psychol; 2013 May; 18(2):244-62. PubMed ID: 23126527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High serum chemerin level in CKD patients is related to kidney function, but not to its adipose tissue overproduction.
    Blaszak J; Szolkiewicz M; Sucajtys-Szulc E; Konarzewski M; Lizakowski S; Swierczynski J; Rutkowski B
    Ren Fail; 2015 Jul; 37(6):1033-8. PubMed ID: 25945605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol and baseline data for a prospective open-label explorative randomized single-center comparative study to determine the effects of various intravenous iron preparations on markers of oxidative stress and kidney injury in chronic kidney disease (IRON-CKD).
    Ziedan A; Bhandari S
    Trials; 2019 Apr; 20(1):194. PubMed ID: 30947751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CKD Increases Carbonylation of HDL and Is Associated with Impaired Antiaggregant Properties.
    Florens N; Calzada C; Lemoine S; Boulet MM; Guillot N; Barba C; Roux J; Delolme F; Page A; Poux JM; Laville M; Moulin P; Soulère L; Guebre-Egziabher F; Juillard L; Soulage CO
    J Am Soc Nephrol; 2020 Jul; 31(7):1462-1477. PubMed ID: 32518085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative Stress in the Pathogenesis and Evolution of Chronic Kidney Disease: Untangling Ariadne's Thread.
    Duni A; Liakopoulos V; Roumeliotis S; Peschos D; Dounousi E
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31362427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.